Indian Institute of Technology Tirupati is an autonomous engineering and technology education institute located in Tirupati, Andra Pradesh. It started functioning from 5 August 2015 in a temporary campus housed at Krishna Theja Educational Institutions in Chadalawada Nagar.

Post : Pharmacist

District Health Society, Zilla Panchayat Office, Health Branch, Surendranagar under the NHM program under 11 months contract basis and then on temporary basis to fill the following various cadre posts, also for future vacant posts.

Post : Pharmacist (RBSK)

No of Posts : 18
Age Limit : 40 years

CDFD, an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, invites applications from Indian nationals for the following purely temporary vacancy in research project titled “Characterization of tumor suppressor function of mRNA 4466” funded by CSIR. CDFD wishes to fill up the following post in the above project.

Post : Senior Research Fellow

Karnataka State Minerals Corporation Limited (KSMCL) has been a dynamic player in the Mining field and has been responsible for the efficient harnessing of these resources.  KSMCL has been involved in the Mining Business since 1966 and today is a recognized name in the industry with high competent and scientific methods to its credit. Capitalizing on this natural resource of Karnataka and acting as an agent of the Government has made KSMCL a vital link in the Local as well as Global trade relations.

Ajanta Pharma Limited, a specialty Pharmaceutical company engaged in development, manufacture and marketing of quality finished dosage in domestic and international markets is looking for suitable candidates for its formulation facility at Guwahati, Assam.

Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of Public Health researchers.

A new study from Washington University School of Medicine in St. Louis suggests a simple blood test administered before CAR-T cell treatment is initiated may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy. Severe side effects can include seizures, brain swelling and strokes. Evidence of a stroke (red arrows) is seen on this MRI scan of the brain of a patient who developed neurotoxic side effects after CAR-T cell therapy.

Biological E. Limited (BE)'s 14-valent paediatric vaccine (investigational pneumococcal polysaccharide conjugate vaccine PCV14) is approved by the Subject Expert Committee of CDSCO  against S. pneumoniae infection in infants.

Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries. With the PCV14 vaccine, Biological E hopes to contribute to the prevention of invasive pneumococcal disease and protect millions of lives globally.

Cervavac was launched on September 1, 2022, after the Drugs Controller General of India had granted market authorization to Serum Institute of India. Cervavac is developed by a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India for the indigenous development of quadrivalent vaccines.

Dr Jitendra Singh said, this affordable and cost effective vaccine marks an important day for DBT and BIRAC as it takes India a step closer to PM Modi’s vision of Atmanirbhar Bharat.

Aurobindo Pharma to invest Rs. 300 crores for expanding its mammalian cell culture manufacturing facility of CuraTeQ Biologics which is a fully owned subsidiary of the Drug maker.

There was a meeting held on 1st september where all the board members agreed to expand its operations by establishing another mammalian cell culture manufacturing facility of higher capacity to cater to the future requirements. The capital expenditure for ramping up capacities is estimated to be around Rs.300 crores.

Novo Nordisk and Forma Therapeutics, Holdings Inc. announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for USD 20 per share in cash, which represents a total equity value of USD 1.1bn. Forma Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the lives of patients with sickle cell disease (SCD) and rare blood disorders.

Novo Nordisk has agreed to pay USD 6.3 million to resolve allegations that it violated the False Claims Act by selling items to the United States that were manufactured in non-designated countries.

The settlement resolves allegations that Novo Nordisk violated the Trade Agreements Act, which restricts the procurement of goods under certain government contracts to purchases from specific designated countries, by submitting false claims for payment for medical devices that were manufactured in non-designated countries.

Caring for the world, one person at a time has inspired and united the people of Johnson & Johnson for over 125 years. We embrace research and science - bringing creative ideas, products and services to advance the health and well-being of people. Every day, our more than 130,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity.

Novartis is making strong immunology portfolio by investing in immunological diseases such as spanning hidradenitis suppurativa (HS), chronic spontaneous urticaria (CSU), Sjogrens syndrome, axial spondyloarthritis, and psoriasis.

Novartis will showcase data from its leading immunology portfolio and emerging pipeline at the upcoming 31st European Academy of Dermatology and Venereology (EADV) Congress and the 15th International Symposium on September 7–10, 2022.

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Heteros business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.

AUROBINDO PHARMA LTD is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over USD 2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations.

Production
Post : Technician / Executives
Granulation, Compression, Capsule Filling, Coating, liquid & Nasal Spray.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

The Arunachal Pradesh, Public Service Commission (APPSC), established in 1988, has been performing its role as the constitutionally mandated guardian of merit and equity in recruitment to the 'Arunachal Pradesh Public Service', with integrity, impartiality and efficiency. Our mission remains, to consolidate public trust by creating and nurturing a Public Service that is Independent, Impartial, Ethical, Effective and Capable enough to meet contemporary challenges faced by the Government and is responsive to the growing expectations of the citizens at large.

The Union Cabinet vide its decision dated 1st May 2013 has approved the launch of National Urban Health Mission (NUHM) as a Sub-mission of an over-arching National Health Mission (NHM), with National Rural Health Mission (NRHM) being the other Sub-mission of National Health Mission. The State PIPs would be an aggregate of the district/city health action plans, and include activities to be carried out at the state level. The state PIP will also include all the individual district/city plans.